Post-weaning effects of milk and milk components on the intestinal mucosa in inflammation.
Many milk-derived components have immunomodulatory and anti-inflammatory properties, and some of these reduce intestinal inflammation when orally administered to animal models of colitis. However, the potential for ruminant milk or milk components to benefit people with intestinal inflammatory disorders (such as Inflammatory Bowel Disease) has not been well-researched. This review describes published research into mechanisms by which ruminant milk and its components may have beneficial effects when consumed by people who have intestinal inflammation.
Russ
Anna
A
Food & Textiles Group, AgResearch, New Zealand.
Barnett
Matthew
M
McNabb
Warren
W
Anderson
Rachel
R
Reynolds
Gordon
G
Roy
Nicole
N
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D006801:Humans; D007249:Inflammation / Q000517:prevention & control*; D015212:Inflammatory Bowel Diseases / Q000178:diet therapy / Q000517:prevention & control*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000276:immunology* / Q000502:physiology; D007422:Intestines; D008892:Milk / Q000737:chemistry / Q000502:physiology*; D008894:Milk Proteins / Q000378:metabolism; D012418:Ruminants; D014886:Weaning
D000893:Anti-Inflammatory Agents; D008894:Milk Proteins